RATNAMANI.NS(RATNAMANI.NS)
RATNAMANI.NS
No analyst ratings available
No analyst price targets available for RATNAMANI.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $50.61B | $58.47B | $70.12B |
| Low | $49.34B | $56.56B | $68.07B |
| High | $51.66B | $59.82B | $71.66B |
| EBITDA Avg | $10.74B | $12.41B | $14.88B |
| Low | $10.47B | $12.00B | $14.45B |
| High | $10.96B | $12.70B | $15.21B |
| EBIT Avg | $9.03B | $10.43B | $12.51B |
| Low | $8.80B | $10.09B | $12.14B |
| High | $9.22B | $10.67B | $12.79B |
| Net Income Avg | $5.48B | $6.61B | $8.35B |
| Low | $4.77B | $6.13B | $8.03B |
| High | $6.07B | $7.09B | $8.58B |
| EPS Avg | $78.09 | $94.23 | $119.00 |
| Low | $68.04 | $87.44 | $114.48 |
| High | $86.52 | $101.12 | $122.40 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $13.10B | $12.61B | $13.08B |
| Low | $13.10B | $12.61B | $13.08B |
| High | $13.10B | $12.61B | $13.08B |
| EBITDA Avg | $2.78B | $2.68B | $2.78B |
| Low | $2.78B | $2.68B | $2.78B |
| High | $2.78B | $2.68B | $2.78B |
| EBIT Avg | $2.34B | $2.25B | $2.33B |
| Low | $2.34B | $2.25B | $2.33B |
| High | $2.34B | $2.25B | $2.33B |
| Net Income Avg | $1.91B | $1.91B | $2.82B |
| Low | $1.91B | $1.91B | $2.82B |
| High | $1.91B | $1.91B | $2.82B |
| EPS Avg | $27.20 | $27.20 | $40.20 |
| Low | $27.20 | $27.20 | $40.20 |
| High | $27.20 | $27.20 | $40.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |